Literature DB >> 1385483

Subclinical ischaemic episodes during the steady state of sickle cell anaemia.

N O Akinola1, S M Stevens, I M Franklin, G B Nash, J Stuart.   

Abstract

AIMS: To determine the clinical, haematological, biochemical and rheological changes that occur in the asymptomatic steady state of sickle cell anaemia.
METHODS: Patient self-assessment visual analogue scores (for wellbeing and tiredness), the blood concentration of acute phase proteins (C-reactive protein, orosomucoid, and fibrinogen), and blood rheology (percentage of dense cells and the number of sickled cells that occluded pores 5 microns in diameter) were studied longitudinally on 10 occasions in each of 20 outpatients with sickle cell anaemia.
RESULTS: Patients in the steady state showed fluctuation in visual analogue scores, in concentration of acute phase proteins, and in rheological parameters consistent with minor episodes of tissue injury. Significantly more variation in acute phase proteins occurred in the steady state of 14 of the 20 patients who developed one or more vaso-occlusive crises during the 16 month study period. Rheological fluctuation in the steady state simulated rheological change during crisis, namely a transient rise and then fall in the number of dense and poorly filterable cells.
CONCLUSIONS: The term "steady state" is a misnomer, being characterised by biochemical and rheological fluctuation consistent with minor episodes of microvascular occlusion that are insufficient to cause the overt tissue infarction of painful crisis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385483      PMCID: PMC495063          DOI: 10.1136/jcp.45.10.902

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis.

Authors:  N O Akinola; S M Stevens; I M Franklin; G B Nash; J Stuart
Journal:  Br J Haematol       Date:  1992-08       Impact factor: 6.998

2.  Erythrocyte density separation on discontinuous "Percoll" gradients.

Authors:  L H Mackie; R S Frank; R M Hochmuth
Journal:  Biorheology       Date:  1987       Impact factor: 1.875

3.  Automated measurement of plasma viscosity by capillary viscometer.

Authors:  B M Cooke; J Stuart
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

4.  Erythrocyte heterogeneity in sickle cell disease: effect of deoxygenation on intracellular polymer formation and rheology of sub-populations.

Authors:  A J Keidan; C T Noguchi; M Player; S M Chalder; J Stuart
Journal:  Br J Haematol       Date:  1989-06       Impact factor: 6.998

5.  The percentage of dense red cells does not predict incidence of sickle cell painful crisis.

Authors:  H H Billett; K Kim; M E Fabry; R L Nagel
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

6.  Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease.

Authors:  C L Neely; T Wajima; A P Kraus; L W Diggs; L Barreras
Journal:  Am J Clin Pathol       Date:  1969-08       Impact factor: 2.493

7.  Fluctuating deformability of oxygenated sickle erythrocytes in the asymptomatic state and in painful crisis.

Authors:  G S Lucas; N M Caldwell; J Stuart
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

Review 8.  Hemoglobin S gelation and sickle cell disease.

Authors:  W A Eaton; J Hofrichter
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

9.  Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells.

Authors:  S K Ballas
Journal:  Am J Hematol       Date:  1991-02       Impact factor: 10.047

10.  Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity.

Authors:  R P Hebbel; M A Boogaerts; J W Eaton; M H Steinberg
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

View more
  21 in total

1.  Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease.

Authors:  Jacqueline M Hibbert; Lewis L Hsu; Sam J Bhathena; Ikovwa Irune; Bismark Sarfo; Melissa S Creary; Beatrice E Gee; Ali I Mohamed; Iris D Buchanan; Ahmad Al-Mahmoud; Jonathan K Stiles
Journal:  Exp Biol Med (Maywood)       Date:  2005-01

2.  Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease.

Authors:  J Stuart; P C Stone; N O Akinola; J R Gallimore; M B Pepys
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

3.  Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.

Authors:  Reham Wagdy; Howayda Suliman; Bashayer Bamashmose; Abrar Aidaroos; Zuhour Haneef; Arunima Samonti; Fatima Awn
Journal:  Eur J Pediatr       Date:  2018-09-07       Impact factor: 3.183

4.  Bayesian analyses demonstrate tissue blood volume is not decreased during acute sickle cell pain episodes: A preliminary study.

Authors:  Maria Perry; Jena Simon; Daniel Gareau; Jeffrey Glassberg
Journal:  Clin Hemorheol Microcirc       Date:  2016       Impact factor: 2.375

5.  Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results.

Authors:  W H Waugh; C W Daeschner; B A Files; M E McConnell; S E Strandjord
Journal:  J Natl Med Assoc       Date:  2001-10       Impact factor: 1.798

6.  Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.

Authors:  Ashaunta Tumblin; Anitaben Tailor; Gerard T Hoehn; A Kyle Mack; Laurel Mendelsohn; Lita Freeman; Xiuli Xu; Alan T Remaley; Peter J Munson; Anthony F Suffredini; Gregory J Kato
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

7.  Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death?

Authors:  J C Romero Mestre; A Hernández; O Agramonte; P Hernández
Journal:  Clin Auton Res       Date:  1997-06       Impact factor: 4.435

8.  Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease.

Authors:  C Moore; M Ehlayel; J Inostroza; L E Leiva; S Kuvibidila; L Yu; R Gardner; D L Ode; R Warrier; R U Sorensen
Journal:  J Natl Med Assoc       Date:  1998-03       Impact factor: 1.798

9.  Small Bowel Ischemia in a Sickle Cell Patient.

Authors:  Shabirhusain S Abadin; Mario R Salazar; Richard Y Zhu; Mark M Connolly; Francis J Podbielski
Journal:  Case Rep Gastroenterol       Date:  2009-03-31

10.  Abnormal pulmonary function in adults with sickle cell anemia.

Authors:  Elizabeth S Klings; Diego F Wyszynski; Vikki G Nolan; Martin H Steinberg
Journal:  Am J Respir Crit Care Med       Date:  2006-03-23       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.